134 related articles for article (PubMed ID: 6572533)
1. Monoclonal antiglycophorin as a probe for erythroleukemias.
Greaves MF; Sieff C; Edwards PA
Blood; 1983 Apr; 61(4):645-51. PubMed ID: 6572533
[TBL] [Abstract][Full Text] [Related]
2. Phenotype of early erythroblastic leukemias.
Villeval JL; Cramer P; Lemoine F; Henri A; Bettaieb A; Bernaudin F; Beuzard Y; Berger R; Flandrin G; Breton-Gorius J
Blood; 1986 Nov; 68(5):1167-74. PubMed ID: 2945604
[TBL] [Abstract][Full Text] [Related]
3. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
4. M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells.
Majdic O; Bettelheim P; Stockinger H; Aberer W; Liszka K; Lutz D; Knapp W
Int J Cancer; 1984 May; 33(5):617-23. PubMed ID: 6724736
[TBL] [Abstract][Full Text] [Related]
5. Glycophorin A on normal and leukemia cells detected by monoclonal antibodies, including a new monoclonal antibody reactive with glycophorins A and B.
Rearden A; Taetle R; Elmajian DA; Majda JA; Baird SM
Mol Immunol; 1985 Apr; 22(4):369-78. PubMed ID: 2412109
[TBL] [Abstract][Full Text] [Related]
6. Myeloid lineage specificity and high sensitivity of monoclonal antibody GM 58/8 proves its usefulness as a diagnostic reagent in acute leukemia.
Das Gupta A; Dhond SR; Barbhaya SA; Advani SH
Am J Hematol; 1987 Jun; 25(2):125-30. PubMed ID: 3300282
[TBL] [Abstract][Full Text] [Related]
7. Early expression of glycophorin C during normal and leukemic human erythroid differentiation.
Villeval JL; Le Van Kim C; Bettaieb A; Debili N; Colin Y; el Maliki B; Blanchard D; Vainchenker W; Cartron JP
Cancer Res; 1989 May; 49(10):2626-32. PubMed ID: 2469535
[TBL] [Abstract][Full Text] [Related]
8. Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.
Fadilah SA; Raja-Zahratul-Azma RS; Leong CF
Malays J Pathol; 2006 Jun; 28(1):55-8. PubMed ID: 17694960
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia.
Liu K; Hu J; Wang X; Li L
J Clin Lab Anal; 2019 Oct; 33(8):e22961. PubMed ID: 31218758
[TBL] [Abstract][Full Text] [Related]
10. Letter: Chemotherapy for erythroleukemia.
Bluming A
N Engl J Med; 1974 Aug; 291(8):419-20. PubMed ID: 4603175
[No Abstract] [Full Text] [Related]
11. Glycophorin A expression in malignant hematopoiesis.
Liszka K; Majdic O; Bettelheim P; Knapp W
Am J Hematol; 1983 Nov; 15(3):219-26. PubMed ID: 6638008
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of antibodies submitted as reactive with glycophorin species.
Telen MJ; Green A; Young T
Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):309-15. PubMed ID: 3212311
[No Abstract] [Full Text] [Related]
13. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
Paolino W; Resegotti L; Rossi M; Infelise V
Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
[TBL] [Abstract][Full Text] [Related]
14. Erythroblastic and/or megakaryoblastic leukemia in Down syndrome: treatment with low-dose arabinosyl cytosine.
Tchernia G; Lejeune F; Boccara JF; Denavit MF; Dommergues JP; Bernaudin F
J Pediatr Hematol Oncol; 1996 Feb; 18(1):59-62. PubMed ID: 8556372
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic heterogeneity of erythroblasts in erythroblastic leukemia revealed by monoclonal antibodies.
Gupta AD; Dhond SR
Am J Hematol; 1988 Sep; 29(1):12-7. PubMed ID: 3052043
[TBL] [Abstract][Full Text] [Related]
16. Late expression of M and N antigens on glycophorin A during erythroid differentiation.
Ekblom M; Gahmberg CG; Andersson LC
Blood; 1985 Jul; 66(1):233-6. PubMed ID: 2408695
[TBL] [Abstract][Full Text] [Related]
17. Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia.
Bettelheim P; Lutz D; Majdic O; Paietta E; Haas O; Linkesch W; Neumann E; Lechner K; Knapp W
Br J Haematol; 1985 Mar; 59(3):395-409. PubMed ID: 3855651
[TBL] [Abstract][Full Text] [Related]
18. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
19. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
Ball ED; Kadushin JM; Schacter B; Fanger MW
J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal antibodies to the antigen of myeloid cells].
Kryzhanov MA; Baryshnikov AIu; Tupitsin NN; Sokolov AV; Frenkel' MA
Biull Eksp Biol Med; 1987 Jul; 104(7):75-7. PubMed ID: 3620654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
